Rituximab therapy after pediatric hematopoietic stem cell transplantation can cause prolonged B-cell impairment and increases the risk for infections - a retrospective matched cohort study

Detalles Bibliográficos
Autores principales: Launspach, Michael, Temel, Dennis, Ohlendorf, Emily, Zirngibl, Felix, Materne, Bianca, Oevermann, Lena, Deubzer, Hedwig E., Henssen, Anton G., Künkele, Annette, Hundsdörfer, Patrick, von Bernuth, Horst, Pruß, Axel, Eggert, Angelika, von Stackelberg, Arend, Lang, Peter, Schulte, Johannes H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Fondazione Ferrata Storti 2022
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9827155/
https://www.ncbi.nlm.nih.gov/pubmed/36134454
http://dx.doi.org/10.3324/haematol.2022.281134

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9827155/
https://www.ncbi.nlm.nih.gov/pubmed/36134454
http://dx.doi.org/10.3324/haematol.2022.281134

Ejemplares similares